Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 3, 2010, Pages 402-407

  Femiano, F ^a   Buonaiuto, C ^a   Gombos, F ^a   Lanza, A ^a   Cirillo, N ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PREDNISOLONE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; APHTHOUS STOMATITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETATES; ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; PREDNISOLONE; QUINOLINES; STOMATITIS, APHTHOUS; TREATMENT OUTCOME;

EID: 77249177029     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.10.024     Document Type: Article

References (34)

1. Bascones-Martinez A., Figuero-Ruiz E., and Esparza-Gomez G.C. Oral ulcers. Med Clin 125 (2005) 590-597
2. Kolseth I., Herlofson B.B., and Pedersen A. Norwegian LongoVital and recurrent aphthous ulceration: a randomized, double-blind, placebo-controlled study. Oral Dis 11 (2005) 374-378
3. Vujevich J., and Zirwas M. Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab. Cutis 76 (2005) 129-132
4. Porter S., and Scully C. Aphthous ulcers (recurrent). Clin Evid (2005) 687-694
5. Chahine L., Sempson N., and Wagoner C. The effect of sodium lauryl sulfate on recurrent aphthous ulcers: a clinical study. Compend Contin Educ Dent 18 (1997) 1238-1240
6. Murray B., McGuinness N., Biagioni P., Hyland P., and Lamey P.J. A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration. J Oral Pathol Med 34 (2005) 413-419
7. Akintoye S.O., and Greenberg M.S. Recurrent aphthous stomatitis. Dent Clin North Am 49 (2005) 31-47
8. Miles D.A., Bricker S.L., Razmus T.F., and Potter R.H. Triamcinolone acetonide versus chlorhexidine for treatment of recurrent stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 75 (1993) 397-402
9. Nolan A., Baillie C., Badminton J., Rudralingham M., and Seymour R.A. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med 35 (2006) 461-465
10. Murray B., Biagioni P.A., and Lamey P.J. The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration. J Oral Pathol Med 35 (2006) 117-122
11. Rodríguez M., Rubio J.A., and Sanchez R. Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis. Oral Dis 13 (2007) 490-494
12. Sun A., Wang J.T., Chia J.S., and Chiang C.P. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations. J Oral Pathol Med 35 (2006) 111-116
13. Pizarro A., Herranz P., García-Tobaruelaa A., and Casado M. Pentoxifylline in the treatment of orogenital aphthosis and Behçet's syndrome. Med Clin 115 (2000) 678
14. Kowolik M.J., Muir K.F., and MacPhee I.T. Di-sodium cromoglycate in the treatment of recurrent aphthous ulceration. Br Dent J 144 (1978) 384-386
15. Altinor S., Oztürkcan S., and Hah M.M. The effects of colchicine on neutrophil function in subjects with recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 17 (2003) 469-470
16. Femiano F., Gombos F., and Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol 42 (2003) 394-397
17. Natah S.S., Konttinen Y.T., Enattah N.S., Ashammakhi N., Sharkey K.A., and Hayrinen-Immonen R. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 33 (2004) 221-234
18. Schmitt-Grohe S., and Zielen S. Leukotriene receptor antagonists in children with cystic fibrosis lung disease: antiinflammatory and clinical effects. Paediatr Drugs 7 (2005) 353-363
19. Stoopler E.T., and Sollectio T.P. Recurrent aphthous stomatitis. Update for the general practitioner. N Y State Dent J 69 (2003) 27-29
20. Kemp J.P. Leukotriene receptor antagonists for the treatment of asthma. IDrugs 3 (2000) 430-441
21. Rahman M.L., Choudhury A.M., and Islam M.M. Effectiveness of montelukast in the treatment of atopic dermatitis. Mymensingh Med J 15 (2006) 85-88
22. Patel P., Philip G., Yang W., Call R., Horak F., LaForce C., et al. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 95 (2005) 551-557
23. Peters-Golden M., and Henderson Jr. W.R. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 94 (2005) 609-618
24. Sener G., Kabasakal L., Cetinel S., Contuk G., Gedik N., and Yegen B.C. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 31 (2005) 587-596
25. Theron A.J., Gravett C.M., Steel H.C., Tintinger G.R., Feldman C., and Anderson R. Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants. Inflamm Res 58 (2009) 263-268
26. Anderson R., Theron A.J., Gravett C.M., Steel H.C., Tintinger G.R., and Feldman C. Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 156 (2009) 105-115
27. Sade K., Kivity S., Fireman E., Schwartz Y., and Kivity S. Effect of montelukast on basophil releasability in patients with asthma. Isr Med Assoc J 7 (2005) 792-795
28. Gurer U.S., Buyukozturk S., Palanduz S., Gurbuz B., and Cevikbas A. Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients. Int Immunopharmacol 3 (2003) 1257-1260
29. Murray J., Ward C., O'Flaherty J.T., Dransfield I., Haslett C., Chilvers E.R., et al. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Br J Pharmacol 139 (2003) 388-398
30. Hemelaers L., Henket M., Sele J., Bureau F., and Louis R. Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy 61 (2006) 136-139
31. Handfield-Jones S., Allen B.R., and Littlewood S.M. Dapsone use with oral-genital ulcers. Br J Dermatol 113 (1985) 501
32. Revuz J., Guillaume J.C., Janier M., Hans P., Marchand C., Souteyrand P., et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 126 (1990) 923-927
33. Fontes V., Machet L., Huttenberger B., Lorette G., and Vaillant L. Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases. Ann Dermatol Venereol 129 (2002) 1365-1369
34. Pizarro A., Navarro A., Fonseca E., Vidaurrazaga C., and Herranz P. Treatment of recurrent aphthous stomatitis with pentoxifylline. Br J Dermatol 133 (1995) 659-660